Back to dashboard
MedicaidBilling CodesMedium impact

Medicaid Alert - MA-1994-02

New Jersey Medicaid·NJ · Nephrology, Oncology, Hematology·Coding
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

New Medicaid billing instructions have been issued for Epoetin alfa (EPO), a medication commonly used to treat anemia in patients with chronic kidney disease or cancer. The policy provides updated coding and billing guidance for this drug.

Action Required

Action needed
Immediately: Billing team should review the full policy document at https://www.njmmis.com/documentDownload.aspx?document=ma1994-02.pdf to understand new EPO billing requirements. Update billing procedures and staff training for Epoetin alfa claims to ensure compliance with new Medicaid guidelines.